CL
CRL icon

Choreo LLC’s Charles River Laboratories CRL Stock Holding History

Choreo LLC’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$478K Sell
2,106
-102
-5% -$18.2K 0.01% 1025
2026
Q1 		$381K Sell
2,208
-10
-0.5% -$1.85K ﹤0.01% 1104
2025
Q4 		$448K Sell
2,218
-93
-4% -$16.9K 0.01% 973
2025
Q3 		$362K Buy
2,311
+277
+14% +$44K ﹤0.01% 1116
2025
Q2 		$309K Buy
2,034
+153
+8% +$20.4K ﹤0.01% 1154
2025
Q1 		$283K Buy
+1,881
New +$315K ﹤0.01% 1123

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Choreo LLC's CRL Position: Q2 2026 in Review

Choreo LLC reduced its Charles River Laboratories (CRL) stake by 4.6% in Q2 2026, selling an estimated $18.2K and leaving 2,106 shares worth $478K. The position accounts for 0.01% of the portfolio, ranked #1025.

Choreo LLC first reported a position in CRL in Q1 2025 and has held it in 6 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Choreo LLC held 2,106 shares of Charles River Laboratories worth $478K as of Q2 2026.
  • Choreo LLC sold 102 Charles River Laboratories shares in Q2 2026, an estimated $18.2K.
  • Charles River Laboratories made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #1025 holding.
  • Choreo LLC first reported a position in Charles River Laboratories in Q1 2025 and has held it in 6 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.